)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Vera Therapeutics
Vera Therapeutics (VERA) investor relations material
Vera Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary9 Apr, 2026
Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting is proposed, with nominees Michael M. Morrissey, Patrick G. Enright, and James R. Meyers.
Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is recommended.
Advisory approval of named executive officer compensation is included as a voting item.
Proxies are authorized to vote on any other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting for all three director nominees for Class II positions.
Executive compensation and say-on-pay
Advisory vote on executive compensation is presented for shareholder approval.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vera Therapeutics
- Director elections, auditor ratification, and executive pay are key 2026 meeting agenda items.VERA
Proxy filing9 Apr 2026 - Atacicept nears FDA approval with strong commercial plans and broad market potential.VERATD Cowen 46th Annual Health Care Conference3 Mar 2026
- FDA priority review and strong cash reserves set the stage for atacicept's 2026 launch.VERAQ4 202526 Feb 2026
- Atacicept demonstrated robust efficacy and safety in IgAN, targeting a multi-billion dollar market.VERACorporate presentation30 Jan 2026
- Atacicept shows robust efficacy in IgA nephropathy, with commercialization targeted for 2026.VERA2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Atacicept nears pivotal data and broad expansion, targeting multiple autoimmune diseases.VERAR&D Day 202419 Jan 2026
- Atacicept achieved durable biomarker reductions and near-normal kidney function over 96 weeks.VERAStudy Result18 Jan 2026
- Atacicept’s strong data and expansion plans position it to transform autoimmune kidney disease care.VERAGuggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026
- Atacicept nears U.S. launch in IgAN with strong data, robust pipeline, and broad market preparation.VERA44th Annual J.P. Morgan Healthcare Conference13 Jan 2026
Next Vera Therapeutics earnings date
Q1 20266 May, 2026
Vera Therapeutics
Next Vera Therapeutics earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage